NCT03372122 is a Phase 4 clinical trial of Chlorhexidine Gluconate in General Skin Cleansing, sponsored by Caroline Scott.

Who is sponsoring NCT03372122?

NCT03372122 is sponsored by Caroline Scott.

What drugs are being tested in NCT03372122?

Interventions in NCT03372122: Chlorhexidine Gluconate, HUBS with Hibiclens.

What condition does NCT03372122 study?

NCT03372122 studies General Skin Cleansing.

Is NCT03372122 still recruiting?

NCT03372122 is currently completed. Last updated 13 March 2018.

Last reviewed 2018-03-13 · How we verify

NCT03372122

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Removal of Bacterial Spores in Adults on Skin

Completed Phase 4 Last updated 13 March 2018

What this trial tests

Phase 4 trial testing Chlorhexidine Gluconate in General Skin Cleansing in 32 participants. Completed in 7 March 2018.

Timeline

13 December 2017

Primary endpoint
8 January 2018

7 March 2018

Quick facts

Lead sponsor	Caroline Scott
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	32
Start date	13 December 2017
Primary completion	8 January 2018
Estimated completion	7 March 2018
Sites	1 location across United States

Drugs / interventions tested

Chlorhexidine Gluconate — full drug profile →
HUBS with Hibiclens

Conditions studied

General Skin Cleansing — all drugs for General Skin Cleansing →

Sponsor

Caroline Scott

Who can join

Adults 18 to 65, any sex, with General Skin Cleansing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effectiveness of removal of spores and dirt from the skin using a single cloth bath against a cloth bath with extra rinse step, to establish whether the extra rinse stage will lead to the removal of a higher level of spores and dirt.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Chlorhexidine Gluconate

Trials testing the same drug.

NCT06464770 — Optimizing Infection Prophylaxis Prior to Shoulder Surgery · NA · recruiting
NCT06305546 — Comparisons Of Different Antiplaque Agents On Gingivitis In Orthodontic Patients · NA · completed
NCT06531720 — Comparison of the Effects of Oral Ulceration Healing in Patients Wearing a Removable Denture · NA · completed
NCT06691841 — Effect of Chlorhexidine Gluconate in Oral Care of Patients With Endotracheal Intubation Based on 16sRNA Technology · NA · completed
NCT05110001 — Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03372122 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Caroline Scott
Last refreshed: 13 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03372122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing